Biden’s Economic Security Blueprint Hands Trump a Loaded Gun
China won’t be the only target for the new U.S. administration.
National Security Advisor Jake Sullivan speaks during a press briefing held in the White House, October 1, 2024. Credit: The White House via Flickr
Over the past four years, the Biden administration has unlocked a formidable set of tools in the name of competing with China. These include extraterritorial export controls on cutting-edge technologies, financial sanctions against Chinese firms, and industrial policies designed to upgrade key industries. If these instruments had been used with strategic patience and in close coordination with allies, they might have achieved their aims. The problem is that, in January, they will be put in the h
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
